Canaccord Genuity Reiterates a 'Buy' on GenMark Diagnostics (GNMK); Pipeline Looking Good

March 9, 2012 10:24 AM EST
Get Alerts GNMK Hot Sheet
Price: $24.04 --0%

Rating Summary:
    2 Buy, 6 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Canaccord Genuity reiterates a 'Buy' on GenMark Diagnostics (NASDAQ: GNMK) price target of $12.00.

Analyst, Jeffrey Frelick, said, "We reiterate our rating and price target on GNMK following the company’s best ever quarter for instrument placements. GNMK reported only select Q4/11 metrics (first year of SOX). We will provide 2013 estimates after the company files its 10-K, likely next week. We continue to like GNMK as a fast-growing pure play in MDx...We lower our ’12 revenue estimate to $11.1M (from $14M) due to lack of flu in Q1."

For an analyst ratings summary and ratings history on GenMark Diagnostics click here. For more ratings news on GenMark Diagnostics click here.

Shares of GenMark Diagnostics closed at $4.03 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst Comments, Analyst EPS Change, Analyst EPS View